Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The pharmaceutical market is dynamic, driven by innovation and the continuous pursuit of more effective and safer treatments. Tenofovir Alafenamide Hemifumarate (TAF Hemifumarate), identified by its CAS number 1392275-56-7, has carved out a significant niche as a critical API in the development of modern antiviral drugs. NINGBO INNO PHARMCHEM provides insights into its applications and market relevance.
TAF Hemifumarate is primarily utilized in the formulation of medications for treating Human Immunodeficiency Virus (HIV) and chronic Hepatitis B Virus (HBV) infections. Its significance stems from its role as a prodrug of tenofovir, offering a superior pharmacokinetic profile compared to its predecessor, Tenofovir Disoproxil Fumarate (TDF). The key advantage of TAF lies in its ability to deliver higher concentrations of the active tenofovir metabolite to target cells while maintaining lower systemic drug levels. This characteristic contributes to a more favorable tenofovir alafenamide safety profile, particularly concerning renal and bone health.
The market presence of TAF Hemifumarate is directly tied to the demand for advanced antiretroviral therapies and Hepatitis B treatments. As global health initiatives continue to focus on managing these viral infections, the demand for APIs like TAF Hemifumarate remains robust. Pharmaceutical companies seeking to develop or manufacture next-generation treatments rely on consistent and high-quality supplies of this API. The specific chemical entity, tenofovir alafenamide fumarate 1392275-56-7, is a key component in many combination therapies that have revolutionized patient care.
The prodrug tenofovir alafenamide benefits are not limited to patient outcomes; they also influence market dynamics. The improved safety profile can lead to better treatment adherence and potentially reduce long-term healthcare costs associated with managing side effects. This makes TAF Hemifumarate an attractive API for pharmaceutical manufacturers. The ongoing research into the applications of tenofovir, including its use in pre-exposure prophylaxis (PrEP) and its role in combination therapies, further solidifies its market position.
NINGBO INNO PHARMCHEM is committed to supporting the pharmaceutical industry by providing access to critical APIs like Tenofovir Alafenamide Hemifumarate. By ensuring the quality and availability of this compound, we contribute to the development of therapies that address significant global health challenges. The continued evolution and application of TAF Hemifumarate underscore its importance in the ongoing fight against viral diseases.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
